GlassScriptPhysician profile
Paul Spano
NPI 1053991562
$6,762.40
in general payments reported to CMS, 2019-2025
7 companies · $3,370 in 2025
The $3,370 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,402 · 2023: $434 · 2024: $1,557 · 2025: $3,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,108 · Travel and Lodging: $733 · Education: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,108.13 |
| Travel and Lodging | $732.60 |
| Education | $519.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,160.84 | 2022-2025 | Variax, Pangea, Mako |
| Arthrex, INC. | $978.60 | 2025 | |
| Southern Edge Orthopaedics, INC. | $699.29 | 2022-2025 | |
| Medical Device Business Services, INC. | $519.99 | 2024-2025 | Actis |
| Depuy Synthes Sales INC. | $368.83 | 2024-2025 | Na, Motoband, Dynaforce |
| Kci USA, INC. | $21.11 | 2022 | |
| Heron Therapeutics, INC. | $13.74 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Spano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.